Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2015, Article ID 796215, 11 pages
http://dx.doi.org/10.1155/2015/796215
Research Article

Human Mesenchymal Stromal Cells Transplantation May Enhance or Inhibit 4T1 Murine Breast Adenocarcinoma through Different Approaches

1Human Genome and Stem-Cell Center (HUG-CELL), Institute of Bioscience, University of São Paulo, 05508-090 São Paulo, SP, Brazil
2Laboratory of Cancer Immunobiology, Department of Microbiology, Immunology and Parasitology, Paulista School of Medicine, Federal University of São Paulo (EPM-UNIFESP), 04023-062 São Paulo, SP, Brazil
3Stomatology Department, Faculty of Dentistry, University of São Paulo, 05508-000 São Paulo, SP, Brazil

Received 26 December 2014; Revised 9 March 2015; Accepted 10 March 2015

Academic Editor: Luca Magnani

Copyright © 2015 T. Jazedje et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Dominici, K. Le Blanc, I. Mueller et al., “Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement,” Cytotherapy, vol. 8, no. 4, pp. 315–317, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Secco, E. Zucconi, N. M. Vieira et al., “Multipotent stem cells from umbilical cord: cord is richer than blood!,” Stem Cells, vol. 26, no. 1, pp. 146–150, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. A. de Mendonça Costa, D. F. Bueno, M. T. Martins et al., “Reconstruction of large cranial defects in nonimmunosuppressed experimental design with human dental pulp stem cells,” Journal of Craniofacial Surgery, vol. 19, no. 1, pp. 204–210, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. D. F. Bueno, I. Kerkis, A. M. Costa et al., “New source of muscle-derived stem cells with potential for alveolar bone reconstruction in cleft lip and/or palate patients,” Tissue Engineering Part A, vol. 15, pp. 427–435, 2009. View at Publisher · View at Google Scholar
  5. N. M. Vieira, V. Brandalise, E. Zucconi et al., “Human multipotent adipose-derived stem cells restore dystrophin expression of Duchenne skeletal-muscle cells in vitro,” Biology of the Cell, vol. 100, no. 4, pp. 231–241, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Jazedje, P. M. Perin, C. E. Czeresnia et al., “Human fallopian tube: a new source of multipotent adult mesenchymal stem cells discarded in surgical procedures,” Journal of Translational Medicine, vol. 7, article 46, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Jazedje, D. F. Bueno, B. V. P. Almada et al., “Human fallopian tube mesenchymal stromal cells enhance bone regeneration in a xenotransplanted model,” Stem Cell Reviews and Reports, vol. 8, no. 2, pp. 355–362, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Downs-Holmes and P. Silverman, “Breast cancer: overview & updates,” Nurse Practitioner, vol. 36, no. 12, pp. 20–26, 2011. View at Publisher · View at Google Scholar
  9. A. E. Karnoub, A. B. Dash, A. P. Vo et al., “Mesenchymal stem cells within tumour stroma promote breast cancer metastasis,” Nature, vol. 449, no. 7162, pp. 557–563, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Okumura, S. S. Wang, S. Takaishi et al., “Identification of a bone marrow-derived mesenchymal progenitor cell subset that can contribute to the gastric epithelium,” Laboratory Investigation, vol. 89, no. 12, pp. 1410–1422, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Djouad, P. Plence, C. Bony et al., “Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals,” Blood, vol. 102, no. 10, pp. 3837–3844, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Sun, K.-H. Roh, J.-R. Park et al., “Therapeutic potential of mesenchymal stromal cells in a mouse breast cancer metastasis model,” Cytotherapy, vol. 11, no. 3, pp. 289–298, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. B. Cousin, E. Ravet, S. Poglio et al., “Adult stromal cells derived from human adipose tissue provoke pancreatic cancer cell death both in vitro and in vivo,” PLoS ONE, vol. 4, no. 7, Article ID e6278, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Y. Khakoo, S. Pati, S. A. Anderson et al., “Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma,” The Journal of Experimental Medicine, vol. 203, no. 5, pp. 1235–1247, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. A. H. Klopp, A. Gupta, E. Spaeth, M. Andreeff, and F. Marini III, “Concise review: dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth?” Stem Cells, vol. 29, no. 1, pp. 11–19, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. F. R. Miller, B. E. Miller, and G. H. Heppner, “Characterization of metastatic heterogeneity among subpopulations of a single mouse mammary tumor: heterogeneity in phenotypic stability,” Invasion and Metastasis, vol. 3, no. 1, pp. 22–31, 1983. View at Google Scholar · View at Scopus
  17. C. J. Aslakson and F. R. Miller, “Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor,” Cancer Research, vol. 52, no. 6, pp. 1399–1405, 1992. View at Google Scholar · View at Scopus
  18. B. L. Eckhardt, B. S. Parker, R. K. van Laar et al., “Genomic analysis of a spontaneous model of breast cancer metastasis to bone reveals a role for the extracellular matrix,” Molecular Cancer Research, vol. 3, no. 1, pp. 1–13, 2005. View at Google Scholar · View at Scopus
  19. F. L. Muehlberg, Y.-H. Song, A. Krohn et al., “Tissue-resident stem cells promote breast cancer growth and metastasis,” Carcinogenesis, vol. 30, no. 4, pp. 589–597, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. A. M. Altman, L. Prantl, F. L. Muehlberg et al., “Wound microenvironment sequesters adipose-derived stem cells in a murine model of reconstructive surgery in the setting of concurrent distant malignancy,” Plastic and Reconstructive Surgery, vol. 127, no. 4, pp. 1467–1477, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Suzuki, R. Sun, M. Origuch et al., “Mesenchymal stromal cells promote tumor growth through the enhancement of neovascularization,” Molecular Medicine, vol. 17, no. 7-8, pp. 579–587, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Shinagawa, Y. Kitadai, M. Tanaka et al., “Mesenchymal stem cells enhance growth and metastasis of colon cancer,” International Journal of Cancer, vol. 127, no. 10, pp. 2323–2333, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. I. I. Slukvin and M. Vodyanik, “Endothelial origin of mesenchymal stem cells,” Cell Cycle, vol. 10, no. 9, pp. 1370–1373, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Shi, Z.-W. Liu, and F.-S. Wang, “Immunomodulatory properties and therapeutic application of mesenchymal stem cells,” Clinical & Experimental Immunology, vol. 164, pp. 1–8, 2011. View at Publisher · View at Google Scholar
  25. M. Baggiolini, B. Dewald, and B. Moser, “Human chemokines: an update,” Annual Review of Immunology, vol. 15, pp. 675–705, 1997. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Fujimoto, T. Sangai, G. Ishii et al., “Stromal MCP-1 in mammary tumors induces tumor-associated macrophage infiltration and contributes to tumor progression,” International Journal of Cancer, vol. 125, no. 6, pp. 1276–1284, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Wang, Y. Li, X. Chen et al., “MCP-1, MIP-1, IL-8 and ischemic cerebral tissue enhance human bone marrow stromal cell migration in interface culture,” Hematology, vol. 7, no. 2, pp. 113–117, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. F. Wang, P. Xu, K.-C. Xie, X.-F. Chen, C.-Y. Li, and Q. Huang, “Effects of tumor microenviromental factors on VEGF expression,” Biomedical Reports, vol. 1, no. 4, pp. 539–544, 2013. View at Publisher · View at Google Scholar
  29. T. Voron, E. Marcheteau, S. Pernot et al., “Control of the immune response by pro-angiogenic factors,” Frontiers in Oncology, vol. 4, article 70, 2014. View at Publisher · View at Google Scholar
  30. P. Barcellos-de-Souza, V. Gori, F. Bambi, and P. Chiarugi, “Tumor microenvironment: bone marrow-mesenchymal stem cells as key players,” Biochimica et Biophysica Acta, vol. 1836, no. 2, pp. 321–335, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Lu, Y. Yuan, X. Wang et al., “The growth inhibitory effect of mesenchymal stem cells on tumor cells in vitro and in vivo,” Cancer Biology & Therapy, vol. 7, no. 2, pp. 245–251, 2008. View at Publisher · View at Google Scholar
  32. M. Secco, C. Bueno Jr., N. M. Vieira et al., “Systemic delivery of human mesenchymal stromal cells combined with IGF-1 enhances muscle functional recovery in LAMA2dy/2j dystrophic mice,” Stem Cell Reviews and Reports, vol. 9, no. 1, pp. 93–109, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. N. M. Vieira, M. Valadares, E. Zucconi et al., “Human adipose-derived mesenchymal stromal cells injected systemically Into GRMD dogs without immunosuppression are able to reach the host muscle and express human dystrophin,” Cell Transplantation, vol. 21, no. 7, pp. 1407–1417, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. M. C. Valadares, J. P. Gomes, G. Castello et al., “Human adipose tissue derived pericytes increase life span in Utrntm1KedDmdmdx /J mice,” Stem Cell Reviews and Reports, vol. 10, no. 6, pp. 830–840, 2014. View at Publisher · View at Google Scholar
  35. M. B. Murphy, K. Moncivais, and A. I. Caplan, “Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine,” Experimental and Molecular Medicine, vol. 45, article e54, 2013. View at Publisher · View at Google Scholar · View at Scopus